Workflow
Ferguson Enterprises Inc.: Notice of Dividend Currency Exchange Rate
Businesswire· 2025-10-20 10:45
NEWPORT NEWS, Va.--(BUSINESS WIRE)--On September 11, 2025, Ferguson Enterprises Inc. (NYSE: FERG; LSE: FERG) announced its intention to pay a dividend of $0.83 per share. The dividend will be paid on November 7, 2025, to stockholders of record as of the close of business on September 26, 2025. Holders of Depositary Interests, being participants within CREST, will receive pounds sterling ("GBP†) as the default currency unless an election is made for payment in an alternative currency. Further de. ...
TELUS Digital Reminds Shareholders to Vote IN FAVOUR of Arrangement with TELUS Corporation
Businesswire· 2025-10-20 10:45
VANCOUVER, British Columbia--(BUSINESS WIRE)--TELUS International (Cda) Inc. ("TELUS Digital†) (NYSE & TSX: TIXT) today issued an important reminder for shareholders to vote IN FAVOUR of the proposed arrangement with TELUS Corporation ("TELUS†) (TSX: T, NYSE: TU) (the "Arrangement†) under which TELUS will acquire all outstanding multiple voting shares and subordinate voting shares of TELUS Digital not already owned by TELUS for US$4.50 per share, reflecting aggregate consideration of US$539. ...
Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2025
Businesswire· 2025-10-20 10:45
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational progress for the third quarter ended September 30, 2025. Planned BLA Submission for Ivonescimab in Q4 2025 Today, Summit announces that, based on the results of the HARMONi clinical trial, it plans to submit a Biologics License Application (BLA) in order to seek approval for ivonescimab plus chemotherapy for this proposed in. ...
Exelixis Announces Data From Zanzalintinib+Atezolizumab Study, Stock Drops In Pre-Market
RTTNews· 2025-10-20 10:42
Exelixis, Inc. (EXEL), Monday announced data from STELLAR-303, evaluating zanzalintinib in combination with atezolizumab versus regorafenib for patients with metastatic colorectal cancer.The combination therapy improved median overall survival to 10.9 months versus 9.4 months with regorafenib, and significantly reduced the risk of death by 20 percent in the intention-to-treat population.The 12- and 24- month survival rate was 46 percent and 20 percent, respectively, for those receiving the combination ther ...
Analysts Laud L’Oréal-Kering Beauty Deal
Yahoo Finance· 2025-10-20 10:40
PARIS – Analysts smiled broadly on news that broke overnight of the sale of Kering Beauty to L’Oréal for 4 billion euros. As previously reported, Kering and L’Oréal jointly said they are forming a long-term strategic partnership in beauty and wellness. More from WWD The binding agreement encompasses the acquisition of the House of Creed by L’Oréal and gives the French beauty giant the rights to enter into a 50-year exclusive license for the creation, development and distribution of fragrance and beauty pr ...
Terrestrial Energy - Is This SPAC Merger About To Go Nuclear?
Seeking Alpha· 2025-10-20 10:40
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Stock markets surge for 4th day; Sensex jumps over 411 points
BusinessLine· 2025-10-20 10:39
Equity benchmark indices Sensex and Nifty ended higher on Monday, taking their winning run to the fourth day in a row, driven by buying in blue-chip Reliance Industries and sustained foreign fund inflows. A sharp rally in global markets also added to the markets' optimism. The 30-share BSE Sensex jumped 411.18 points or 0.49 per cent to settle at 84,363.37. During the day, it zoomed 704.37 points or 0.83 per cent to 84,656.56. The 50-share NSE Nifty surged 133.30 points or 0.52 per cent to 25,843.15. From t ...
Getty Images Merger With Shutterstock Raises U.K. Competition Issues, Regulator Says
WSJ· 2025-10-20 10:36
Group 1 - The image companies have agreed to merge, creating a new entity valued at approximately $3.7 billion, including debt [1]
Interview: ‘underperformance is punished more than outperformance is rewarded' says analyst Joshua Mahony on Wall Street outlook
Invezz· 2025-10-20 10:35
false Trading Ideas Stock Market Crypto Forex Economic Commodity Video World Interview: 'underperformance is punished more than outperformance is rewarded' says analyst Joshua Mahony on Wall Street outlook Written by Devesh KumarDevesh K. Devesh Kumar Sub-Editor Devesh Kumar Sub-Editor Devesh is a sub-editor at Invezz, where he writes and edits news reports. He is dedicated to clear communication, collaborative teamwork, and delivering practical financial insights. read more. Written onOct 20, 2025 Reading ...
Apple faces new antitrust complaint in China as users allege app store monopoly
Invezz· 2025-10-20 10:35
Core Viewpoint - Apple is facing allegations of monopolistic practices in app distribution and payment systems in China, as 55 local iPhone and iPad users have filed a complaint [1] Group 1 - The complaint highlights concerns regarding Apple's control over app distribution and payment methods, suggesting potential anti-competitive behavior [1]